Repurposing strategies on pyridazinone-based series by pharmacophore- and structure-driven screening

We report here in silico repurposing studies on 52 new pyridazinone-based small-molecules through inverse virtual screening (iVS) methodologies. These analogues were originally designed as formyl peptide receptor (FPR) ligands. As it is sometimes the case in drug discovery programmes, subsequent bio...

Descripción completa

Detalles Bibliográficos
Autores principales: Floresta, Giuseppe, Crocetti, Letizia, Giovannoni, Maria Paola, Biagini, Pierfrancesco, Cilibrizzi, Agostino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241479/
https://www.ncbi.nlm.nih.gov/pubmed/32367744
http://dx.doi.org/10.1080/14756366.2020.1760261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241479/
https://www.ncbi.nlm.nih.gov/pubmed/32367744
http://dx.doi.org/10.1080/14756366.2020.1760261

Ejemplares similares